TJL Enterprises on Wednesday introduced Tummy Calm, a natural gas relief remedy for infants and children.

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

The National Association of Chain Drug Stores submitted on Monday comments to the Food and Drug Administration regarding its position on the “new paradigm” for a third class of drugs.

The battle for public opinion and legislative sway was in full swing Monday as executives from the National Community Pharmacists Association lobbied congressional leaders regarding several pieces of "pro-patient, pro-pharmacist legislation." To counter that effort, the Pharmaceutical Care Management Association issued some marketing firepower of its own.

Researchers from the Duke University Medical Center on Monday released a public health study finding that even maintaining the current prevalence of obesity in the United States would realize savings of almost $550 billion over the next two decades.

Walgreens on Monday announced it has completed its acquisition of certain assets of BioScrip’s community specialty pharmacies and centralized specialty and mail-service pharmacy businesses.

Eruption on Thursday launched its Eruption Effervescent Energy, an energy powder supplement that can be added to any beverage.

Manchester College has tapped Dave McFadden to serve as the dean of the university's pharmacy school.

The Little Clinic has announced that it has earned reaccreditation from the Joint Commission by continuing to demonstrate compliance with the highest national standards for healthcare safety and quality of care.

Generic drug maker Watson Pharmaceuticals has appointed Lisa DeFrancesco as its VP global investor relations, the company said Friday.